Machine Learning-Based A Priori Chemotherapy Response Prediction in Breast Cancer Patients using Textural CT Biomarkers .

Early prediction of cancer response to neoadjuvant chemotherapy (NAC) could permit personalized treatment adjustments for patients, which would improve treatment outcomes and patient survival. For the first time, the efficiency of quantitative computed tomography (qCT) textural and second derivative of textural (SDT) features were investigated and compared in this study. It was demonstrated that intra-tumour heterogeneity can be probed through these biomarkers and used as chemotherapy tumour response predictors in breast cancer patients prior to the start of treatment. These features were used to develop a machine learning approach which provided promising results with cross-validated AUC0.632+, accuracy, sensitivity and specificity of 0.86, 81%, 74% and 88%, respectively.Clinical Relevance- The results obtained in this study demonstrate the potential of textural CT biomarkers as response predictors of standard NAC before treatment initiation.